Neurotoxicant-induced inflammatory response in three-dimensional brain cell cultures

Abstract

Brain inflammatory response is triggered by the activation of microglial cells and astrocytes in response to various types of CNS injury, including neurotoxic insults. Its outcome is determined by cellular interactions, inflammatory mediators, as well as trophic and/or cytotoxic signals, and depends on many additional factors such as the intensity and duration of the insult, the extent of both the primary neuronal damage and glial reactivity and the developmental stage of the brain. Depending on particular circumstances, the brain inflammatory response can promote neuroprotection, regeneration or neurodegeneration. Glial reactivity, regarded as the central phenomenon of brain inflammation, has also been used as an early marker of neurotoxicity. To study the mechanisms underlying the glial reactivity, serum-free aggregating brain cell cultures were used as an in vitro model to test the effects of conventional neurotoxicants such as organophosphate pesticides, heavy metals, excitotoxins and mycotoxins. This approach was found to be relevant and justified by the complex cell—cell interactions involved in the brain inflammatory response, the variability of the glial reactions and the multitude of mediators involved. All these variables need to be considered for the elucidation of the specific cellular and molecular reactions and their consequences caused by a given chemical insult. Human & Experimental Toxicology (2007) 26, 339—346

Keywords

aggregating brain cell cultures astrocyte brain inflammation chlorpyrifos fumonisin B1 (FB1)glial fibrillary acidic protein (GFAP)glial reactivity gliosis lead mercury microglia mycotoxins ochratoxin A (OTA)organophosphate pesticides (OPs)parathion trimethyltin (TMT)

References

Fontana A. Astrocytes and lymphocytes: intercellular communication by growth factors . J Neurosci Res 1982; 8: 443—51.

Aschner M. Astrocytes as mediators of immune and inflammatory responses in the CNS. Neurotoxicology 1998; 19: 269—81.

Aschner M. , Allen JW , Kimelberg HK , LoPachin RM , Streit WJ Glial cells in neurotoxicity development. Annu Rev Pharmacol Toxicol 1999; 39: 151—73.

Streit WJ , Walter SA , Pennell NA Reactive microgliosis. Prog Neurobiol 1999 ; 57: 563—81.

Aschner M. , LoPachin RM Astrocytes: Targets and mediators of chemical-induced CNS injury. J Toxicol Environ Health 1993; 38: 329—42.

Monnet-Tschudi F. , Zurich MG , Honegger P. Evaluation of the toxicity of different metal compounds in the developing brain using aggregating cell cultures as a model . Toxicol In Vitro 1993; 7: 335—39.

Honegger P. , Schilter B. The use of serum-free aggregating brain cell cultures in neurotoxicology. In: Chang LW ed. Neurotoxicology: approaches & methods. Academic Press, New York, 1995: 507—16.

Zurich MG , Monnet-Tschudi F. , Costa LG , Schilter B. , Honegger P. Aggregating brain cell cultures for neuro-toxicological studies. In Tiffani-Castiglioni E ed. Methods in pharmacology and toxicology: in vitro neurotoxicology: principles and challenges, 2004. Humana Press Inc., Totowa, NJ, 2004: 243—66.

Monnet-Tschudi F. , Zurich, MG , Honegger P. Comparison of the developmental effects of two mercury compounds on glial cells and neurons in aggregate cultures of rat telencephalon. Brain Res 1996; 741: 52—59.

10.

Monnet-Tschudi F. , Zurich MG , Schilter B. , Costa L. , Honegger P. Maturation-dependent effects of chlorpyrifos and parathion and their oxygen analogs on acetylcholinesterase and neuronal and glial markers in aggregating brain cell cultures. Toxicol Appl Pharmacol 2000; 165: 175—83.

11.

Zurich MG , Honegger P. , Schilter B. , Costa LG , Monnet-Tschudi F. Use of aggregating brain cell cultures to study developmental effects of organophosphorus insecticides. Neurotoxicology 2000; 21: 599—606.

12.

Zurich MG , Eskes C. , Honegger P. , Bérode M. , Monnet-Tschudi F. Maturation-dependent neurotoxicity of lead acetate in vitro: implication of glial reactions. J Neurosci Res 2002; 70: 108—16.

13.

Zurich MG , Lengacher S. , Braissant O. , Monnet-Tschudi F. , Pellerin L. , Honegger P. Unusual astrocyte reactivity caused by the food mycotoxin Ochratoxin A in aggregating rat brain cell cultures. Neuroscience 2005; 134: 771—82.

14.

Maier WE , Brown HW , Tilson HA , Luster MI , Harry GJ Trimethyltin increases interleukin (IL)-1β, IL-6 and tumor necrosis factor α mRNA levels in rat hippocampus. J Neuroimmunol 1995; 59: 65—75.

15.

McCann MJ , O'Callaghan JP , Martin PM , Bertram T. , Streit WJ Differential activation of microglia and astrocytes following trimethyl tin-induced neurodegeneration. Neuroscience 1996; 72: 273—81.

16.

Kuhlmann AC , Guilarte TR Cellular and subcellular localization of peripheral benzodiazepine receptors after trimethyltin neurotoxicity. J Neurochem 2000; 74: 1694—704.

17.

Monnet-Tschudi F. , Zurich MG , Pithon E. , van Melle G. , Honegger P. Microglial responsiveness as a sensitive marker for trimethyltin (TMT) neurotoxicity. Brain Res 1995; 690: 8—14.

18.

Monnet-Tschudi F. , Zurich MG , Riederer BM , Honegger P. Effects of trimethyltin (TMT) on glial and neuronal cells in aggregate cultures: dependence on the developmental stage . Neurotoxicology 1995; 16: 97—104.

19.

Svensson M. , Eriksson NP , Aldskogius H. Evidence for activation of astrocytes via reactive microglial cells following hypoglossal nerve transection. J Neurosci Res 1993; 35: 373—81.

20.

Chiang C-S. , Stalder A. , Samimi A. , Campbell IL Reactive gliosis as a consequence of interleukin-6 expression in the brain: studies in transgenic mice. Dev Neurosci 1994; 16: 212—21.

21.

Ridet JL , Malhotra SK , Privat A. , Gage FH Reactive astrocytes: cellular and molecular cues to biological function. TINS 1997; 20: 570—77.

22.

Eskes C. , Honegger P. , Juillerat-Jeanneret L. , Monnet-Tschudi F. Microglial reaction induced by non-cytotoxic methylmercury treatment leads to neuroprotection via interactions with astrocytes and IL-6 release. Glia 2002; 37: 43—52.

23.

Aschner M. , Chen R. , Kimelberg HK Effects of mercury and lead on rubidium uptake and efflux in cultured rat astrocytes. Brain Res Bull 1991; 26: 639—42.

24.

Aschner M.

Methylmercury in astrocytes — what possible significance ?

Neurotoxicology 1996; 17: 93—106.

25.

Banati RB , Gehrmann J. , Schubert P. , Kreutzberg GW Cytotoxicity of microglia. Glia 1993; 7: 111—18.

26.

Zurich MG , Honegger P. , Schilter B. , Costa LG , Monnet-Tschudi F. Involvement of glial cells in the neurotoxicity of parathion and chlorpyrifos . Toxicol Appl Pharmacol 2004; 201: 97—104.

27.

Chao CC , Hu S. , Peterson PK Glia, cytokines, and neurotoxicity. Critical Rev Neurobiol 1995; 9: 189—205.

28.

Eskes C. , Juillerat-Jeanneret L. , Leuba G. , Honegger P. , Monnet-Tschudi F. Involvement of microglia-neuron interactions in the TNF-α release, microglial activation and neurodegeneration induced by trimethyltin. J Neurosci Res 2003; 71: 583—90.

29.

Eng LF , Ghirnikar RS , Lee YL Glial Fibrillary Acidic Protein: GFAP — Thirty-one years (1969—2000) . Neurochem Res 2000; 25: 1439—51.

30.

Schmalenbach C. , Müller HW Astroglia-Neuron interactions that promote long-term neuronal survival. J Chem Neuroanat 1993; 6: 229—37.

31.

Eng LF , Ghirnikar RS GFAP and astrogliosis. Brain Pathol 1994; 4: 229—37.

32.

Neary JT , Kang Y. Signaling from p2 nucleotide receptors to protein kinase cascades inducedby CNS injury: implications for reactive gliosis and neurodegenneration. Mol Neurobiol 2005; 31: 95—104.

33.

Nawashiro H. , Messing A. , Azzam N. , Brenner M. Mice lacking GFAP are hypersensitive to traumatic cerebrospinal injury. Neuroreport 1998; 9: 1691—96.

34.

Galea E. , Duponey P. , Feinstein DL Glial fibrillary acidic protein mRNA isotypes: Expression in vitro and in vivo. J Neurosci Res 1995; 41: 452—61.

35.

Huang AM , Lee Ehy. Identification of a novel glial fibrillary acidic protein mRNA isotype related to memory retention in rats. Neuroreport 1997 ; 8: 1619—24.

36.

Steward O. , Kelley MS , Schauwecker PE Signals that regulate astroglial gene expression: Induction of GFAP mRNA following seizures or in jury is blocked by protein synthesis inhibitor. Exp Neurol 1997; 148: 100—109.

37.

Tani M. , Glabinski AR , Tuohy VK , Stoler MH , Ester ML , Ransohoff RM In situ hybridization analysis of glial fibrillary acidic protein mRNA reveals evidence of biphasic astrocyte activation during acute experimental autoimmune encephalomyelitis. Am J Pathol 1996; 148: 889—96.

38.

Brenner M. Glial fibrillary acidic protein (GFAP). Brain Pathol 1994; 4: 219—20.

39.

Wu VW , Nishiyama N. , Schwartz JP A culture model of reactive astrocytes: Increased nerve growth factor synthesis and reexpression of cytokine responsiveness. J Neurochem 1998; 71: 749—56.

40.

Martin PM , O'Callaghan JP A direct comparison of GFAP immunocytochemistry and GFAP concentration in various regions of ethanol-fixed rat and mouse brain. J Neurosci Methods 1995; 58: 181—92.

41.

Pekny M. , Pekna M. Astrocyte intermediate filaments in CNS pathologies and regeneration. J Pathol 2004; 204: 428—37.

42.

Charleston JS , Body RL , Bolender RP , Mottet NK , Vahter ME , Burbacher TM Changes in the number of astrocytes and microglia in the thalamus of the monkey Macaca fascicularis following long-term subclinical methylmercury exposure. Neurotoxicology 1996 ; 17: 127—38.

43.

O'Callaghan JP Assessment of neurotoxicity: use of glial fibrillary acidic protein as a biomarker. Biomed Environ Sci 1991; 4: 197—206.

44.

O'Callaghan JP Neurotypic and gliotypic proteins as biochemical markers of neurotoxicity. Neurotoxicol Teratol 1988; 10: 445—52.

45.

O'Callaghan JP , Sriram K. Glial fibrillary acidic protein and related glial proteins as biomarkers of neurotoxicity. Expert Opin Drug Saf 2005; 4: 433—42.

46.

Chamberlain WJ , Bacon CW , Norred WP , Voss KA Levels of fumonisin B1 in corn naturally contaminated with aflatoxins. Food Chem Toxicol 1993; 31: 995—98.

47.

Pfohl-Leszkowicz A. L'ochratoxine A, mycotoxine ubiquitaire, contaminant l'alimentation humaine. Comptes Rendus Séances Soc Biol Fil 1994; 188: 335—53.

48.

Belmadani A. , Tramu G. , Betbeder AM , Baudrimont I. , Creppy EE Regional selectivity to Ochratoxin A, distribution and cytotoxicity in rat brain. Arch Toxicol 1998; 72: 656—62.

49.

Dortant PM , Peters-Volleberg Gvw , Van Loveren H , Marquardt RR , Speijers Gja. Age-related differences in the toxicity of ochratoxin A in female rats. Food Chem Toxicol 2001; 39: 55—65.

50.

Hong J. , Park KS , Han SY , Park KS , Kim HS , Oh SD , Lee RD , Jang SJ Effects of ochratoxin A on cytotoxicity and cell differentiation in cultured rat embryonic cells. J Toxicol Environ Health 2000; 61: 609—21.

51.

Miki T. , Fukui Y. , Uemura N. , Takeuchi Y. Regional difference in the neurotoxicity of ochratoxin A on the developing cerebral cortex in mice. Dev Brain Res 1994 ; 82: 259—64.

52.

Monnet-Tschudi F. , Sorg O. , Honegger P. , Zurich M-G. , Huggett AC , Schilter B. Effects of naturally occurring food mycotoxin ochratoxin A on brain cells in culture. Neurotoxicology 1997; 18: 831—40.

53.

Monnet-Tschudi F. , Zurich M-G. , Sorg O. , Matthieu J.-M. , Honegger P. , Schilter B. The naturally occuring food mycotoxin fumonisin B1 impairs myelin formation in aggregating brain cell culture. Neurotoxicology 1999; 20: 41—48.

54.

Calvo JL , Carbonell AL , Boya J. Co-expression of glial fibrillary acidic protein and vimentin in reactive astrocytes following brian injury in rats. Brain Res 1991; 566: 333—36.

55.

Eddleston M. , Mucke L. Molecular profile of reactive astrocyte. Implication for their role in neurologic disease. Neuroscience 1993; 54: 15—36.

56.

Norenberg MD Astrocyte responses to CNS injury. J Neuropathol Exp Neurol 1994; 53: 213—20.

57.

Wu VW , Schwartz JP Cell culture models for reactive gliosis: New perspectives. J Neurosci Res 1998; 51: 675—81.

58.

Roymans D. , Vissenberg K. , De Jonghe C , Grobben B. , Claes P. , Verbelen JP , Van Broeckhoven C , Siegers H. Phosphatidyllinositol 3-kinase activity is required for the expression of glial fibrillary acidic protein upon cAMP-dependent induction of differentiation in rat C6 glioma. J Neurochem 2001; 76: 610—18.

59.

Balasingam V. , Tejada-Berges T. , Wright E. , Bouckova R. , Yong VW Reactive astrogliosis in the neonatal mouse brain and its modulation by cytokines. J Neurosci 1994; 14: 846—56.

60.

Yong VW Response of astrocytes and oligodendrocytes to injury. Mental Retard Dev Disabil Res Rev 1998; 4: 193—99.

61.

Balasingam V. , Dickson K. , Brade A. , Wee Yong Voon. Astrocyte reactivity in neonatal mice: apparent dependance on the presence of reactive microglia/ macrophages. Glia 1996; 18: 11—26.

62.

Mushak P. , Davis JM , Crocetti AF , Grant LD Prenatal and postnatal effects of low-level exposure: integrated summary of a report to the US Congress on childhood lead poisonning. Environ Res 1989; 50: 11—36.

63.

Davis JM , Otto DA , Weil DE , Grant LD The comaparative developmental neurotoxicity of lead in humans and animals . Neurotoxicol Teratol 1990; 12: 215—29.

64.

Han S. , Qiao X. , Kemp FW , Bogden JD Lead exposure at an early age substantially increases lead retention in the rat. Env Health Perspect 1997; 105: 412—17.

65.

Lindhal LS , Bird L. , Legare ME , Mikeska G. , Bratton GR , Tiffany-Castiglioni E. Differential ability of astroglia and neural cells to accumulate lead: Dependence on cell type and on degree of differentiation. Toxicol Sci 1999; 50: 236—43.

66.

Bielarczyk H. , Tamsig JL , Suszkiw JB Perinatal low-level lead exposure and the septohippocampal cholinergic system: selective reduction of muscarinic receptors and cholineacetyltransferase in the rat septum. Brain Res 1994; 643: 211—17.

67.

Gallo V. , Ghiani CA Glutamate receptors in glia, new cells, new inputs and new functions. Trends Pharmacol Sci 2000; 21: 252—58.

68.

Hopkins KJ , Wang GJ , Schmued LC Temporal progression of kainic acid induced neuronal and myelin degeneration in the rat forebrain. Brain Res 2000; 864: 69—80.

69.

Cicarelli R. , Ballerini P. , Sabatino G. , Rathboen MP , D'Onofrio M. , Caciagli F. , Dilorio P. Involvement of astrocytes in purine-mediated reparative processes in the brain. Int J Devl Neurosci 2001; 19: 395—414.

70.

Chao CC , Hu S. Tumor necrosis factor-alpha potentiates glutamate neurotoxicity in human fetal brain cell cultures. Dev Neurosci 1994; 16: 172—79.

71.

Piani D. , Fontana A. Involvement of the cystine transport system xc— in the macrophage-induced glutamate-dependent cytotoxicity to neurons. J Immunol 1994; 152: 3578—85.

72.

Park KW , Lee DY , Joe EH , Kim SU , Jin BK Neuroprotective role of microglia expressing interleukin-4. J Neurosci Res 2005; 81: 397—402.

73.

Acarin L. , Peluffo H. , Barbeito L. , Castellano B. , Gonzalez B. Astroglial nitration after postnatal excitotoxic damage: correlation with nitric oxide sources, cytoskeletal, apoptotic and antioxidant proteins. J Neurorauma 2005; 22: 189—200.

74.

Hong JT , Lee MK , Park KS , Jung KM , Park KL , Yang KH , Chung SY Inhibitory effect of peroxisome proliferator-activated receptor gamma agonist on ochratoxin A-induced cytotoxicity and activation of transcription factors in cultured rat embryonic midbrain cells. J Toxicol Environ Health 2002; 65: 407—18.

75.

Raivich G. , Bohatsschek M. , Kloss Cva , Werner A Jones LL , Kreutzberg GW Neuroglial activation repertoire in the injured brain: graded response, molecular mechanisms and cues to physiological functions. Brain Res Rev 1999; 30: 77—105.

76.

Bates KA , Fonte J. , Robertson R. , Martins RN , Harvey AR Chronic gliosis triggers Alzheimer's disease-like processing of amyloid precursor protein. Neuroscience 2002; 113: 785—96.